| # | Drug | Count |
|---|---|---|
| 0 | PANCRELIPASE | 18 |
| 1 | PANTOPRAZOLE | 14 |
| 2 | NIVOLUMAB | 12 |
| 3 | ACETAMINOPHEN | 11 |
| 4 | ONDANSETRON | 11 |
| 5 | ONDANSETRON HYDROCHLORIDE | 11 |
| 6 | ONDANSETRON TABLETS | 11 |
| 7 | ADALIMUMAB | 10 |
| 8 | ASPIRIN | 10 |
| 9 | ASPIRIN 325 MG | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE | 1 | 0.0132 |
| 1 | DEXBROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0123 |
| 2 | VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR | 1 | 0.0013 |
| 3 | SACCHAROMYCES CEREVISIAE | 1 | 0.0011 |
| 4 | HYALURONIC ACID | 1 | 0.0009 |
| 5 | SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM | 1 | 0.0007 |
| 6 | FLUNISOLIDE | 1 | 0.0007 |
| 7 | INSULIN DEGLUDEC AND LIRAGLUTIDE | 1 | 0.0006 |
| 8 | RYDAPT | 1 | 0.0005 |
| 9 | EVEROLIMUS TABLETS | 8 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 1 | Corticosteroid [EPC] | 14 |
| 2 | Kinase Inhibitor [EPC] | 14 |
| 3 | Opioid Agonist [EPC] | 12 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 12 |
| 5 | Serotonin-3 Receptor Antagonist [EPC] | 11 |
| 6 | Benzodiazepine [EPC] | 10 |
| 7 | CTLA-4-directed Blocking Antibody [EPC] | 10 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 10 |
| 9 | Platinum-based Drug [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 1 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 2 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 3 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 4 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 5 | Stimulant Laxative [EPC] | 4 | 0.0003 |
| 6 | Chloride Channel Activator [EPC] | 2 | 0.0002 |
| 7 | CTLA-4-directed Blocking Antibody [EPC] | 10 | 0.0002 |
| 8 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 9 | Cannabinoid [EPC] | 1 | 0.0001 |